NASDAQ:ESLAW

Estrella Immunopharma, Inc.

Read ESLAW's Filings Free

Company facts

Most recent report
10-Q, filed Aug 13, 2026
Filings on record
251 filings
On EDGAR
CIK 1844417
Fiscal year ends
December
Filer status
Non-accelerated filer Smaller reporting company Emerging growth company

Financials 8 of 21

News 8 of 61

Prospectuses and Registrations 8 of 45

Proxies 7

Ownership 8 of 47

Other 8 of 70

Everything here comes from Estrella Immunopharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.